Douglas Whitman
Analyst · BMO Capital Markets
Thank you, David. First, a brief comment on recent capital market activity. The company completed a $201 million follow-on equity offering at the end of the third quarter to fund the completion of the 2 Mercy Health projects and an anticipated $50 million of fourth quarter acquisition. With the company's closing $71.4 million of acquisitions in the fourth quarter, $16.2 million acquisition in late January and a mortgage payoff of $14.7 million this month, the company activated its existing ATM program in January. During the month, the company issued 1.6 million shares at an average gross price of $25.19 per share and generated net proceeds of $39.7 million. Looking ahead, the company may, from time to time, use its ATM to match funds to small to midsize acquisitions. Last week, the company closed on an extension of its revolving credit facility with 15 banks, all of them participants from our original October 2011 facility. The overall facility size remained unchanged at $700 million and we extended the term until April 2017. In addition, the company has the option to add an additional year, which would extend the maturity until April 2018. Pricing for this credit facility also improved. The annual facility fee for the revolver will decline from 35 to 30 basis points and the LIBOR spread will fall from 150 to 140 basis points. As a result, the company will pay lower fees and less interest each year and gain 18 months of additional term. Now I'd like to direct your attention to our supplemental schedule. We have modified and enhanced our disclosures to provide investors and analysts with more insight into the characteristics of our portfolio and certain corporate financial measures. For example, in the summary of indebtedness table on Page 6, we now detailed the credit facility fees and deferred financing cost that were often overlooked by investors in estimating interest expense. In addition, as the healthcare landscape continues to evolve and the importance of working with the right healthcare system is critical, we have begun, on Page 11, to provide additional detail on the scope of our relationships with health systems, including their credit rating. Nearly 80% of our portfolio is associated with a credit-rated provider and nearly 60% with an investment-grade health system. This past year, we added a new table to the supplemental entitled, Components of NAV, which sought to provide investors not only with a common framework for valuing the company, but also with greater clarity into those parts of the company whose value was often misunderstood or overlooked. Following up on that addition, we have added a new schedule entitled, Components of Expected 2013 FFO. This schedule, found on Page 17 of our supplemental, will guide investors and analysts in their financial modeling by providing ranges and estimates of several key operating and financial metrics for the upcoming year. In addition, in our investor presentation, which is available on our website, we have updated and added several slides. For example, we added a chart to Page 8 that compares overall U.S. employment with several employment categories related to outpatient medical care. While the broader U.S. jobs picture remains murky, we continue to see steady job growth in areas such as physician’s office and outpatient medical centers. Page 24 of the presentation highlights our cash releasing yields. This slide illustrates how a common real estate metric, cash releasing spreads, only focuses on one aspect of a lease renewal, namely the change in the rental rate. However, that measure ignores several other factors that contribute to the overall economics of a lease renewal, such as future rental increases, the amount of tenant improvement dollars and the length of the lease term. Taken together, these factors, along with others, provide a more comprehensive measure of the lease renewal's overall impact. In the fourth quarter, our cash releasing spread for our multi-tenant properties was 1%, generally in line with recent quarters. And our releasing yields on 2012 renewals increased 22 basis points from 10.16% to 10.38%, which is also in keeping with our historical range. Finally, Page 25 of the presentation looks at a common debt metric, debt-to-EBITDA, and how our safer but lower yielding property type, MOBs, can paradoxically compare less favorably to other higher-risk healthcare property types. For example, within the healthcare REIT sector, there are several companies with similar debt-to-EBITDA ratios with significantly different balance sheets. We will be attending a pair of investor conferences in New York next week and in early April and expect to see many of you there. David?